TY - JOUR
T1 - Functional materials based on molecules with hydrogen-bonding ability
T2 - Applications to drug co-crystals and polymer complexes
AU - Hutchins, Kristin M.
N1 - Publisher Copyright:
© 2018 The Authors.
PY - 2018/6/18
Y1 - 2018/6/18
N2 - The design, synthesis and property characterization of new functional materials has garnered interest in a variety of fields. Materials that are capable of recognizing and binding with small molecules have applications in sensing, sequestration, delivery and property modification. Specifically, recognition of pharmaceutical compounds is of interest in each of the aforementioned application areas. Numerous pharmaceutical compounds comprise functional groups that are capable of engaging in hydrogen-bonding interactions; thus, materials that are able to act as hydrogen-bond receptors are of significant interest for these applications. In this review, we highlight some crystalline and polymeric materials that recognize and engage in hydrogen-bonding interactions with pharmaceuticals or small biomolecules. Moreover, as pharmaceuticals often exhibit multiple hydrogen-bonding sites, many donor/acceptor molecules have been specifically designed to interact with the drug via such multiple-point hydrogen bonds. The formation of multiple hydrogen bonds not only increases the strength of the interaction but also affords unique hydrogen-bonded architectures.
AB - The design, synthesis and property characterization of new functional materials has garnered interest in a variety of fields. Materials that are capable of recognizing and binding with small molecules have applications in sensing, sequestration, delivery and property modification. Specifically, recognition of pharmaceutical compounds is of interest in each of the aforementioned application areas. Numerous pharmaceutical compounds comprise functional groups that are capable of engaging in hydrogen-bonding interactions; thus, materials that are able to act as hydrogen-bond receptors are of significant interest for these applications. In this review, we highlight some crystalline and polymeric materials that recognize and engage in hydrogen-bonding interactions with pharmaceuticals or small biomolecules. Moreover, as pharmaceuticals often exhibit multiple hydrogen-bonding sites, many donor/acceptor molecules have been specifically designed to interact with the drug via such multiple-point hydrogen bonds. The formation of multiple hydrogen bonds not only increases the strength of the interaction but also affords unique hydrogen-bonded architectures.
KW - Co-crystal
KW - Hydrogen bonding
KW - Pharmaceuticals
KW - Polymer
UR - http://www.scopus.com/inward/record.url?scp=85049362219&partnerID=8YFLogxK
U2 - 10.1098/rsos.180564
DO - 10.1098/rsos.180564
M3 - Review article
AN - SCOPUS:85049362219
SN - 2054-5703
VL - 5
JO - Royal Society Open Science
JF - Royal Society Open Science
IS - 6
M1 - 180564
ER -